Effects of Vortioxetine (Lu AA21004) on the Concentrations of Selected Neurotransmitters in Healthy Male Adults
Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the pharmacodynamics (the drug's effect on the
body), the pharmacokinetics (the body's handling of the drug), and the safety and
tolerability of vortioxetine, once daily (QD) in healthy men.